The nation’s largest health insurer, UnitedHealth Group, is facing increasing scrutiny over its Medicare Advantage (MA) practices, specifically allegations of systematically inflating risk assessments to maximize profits. This practice, known as upcoding
, could lead to improper payments from the government and perhaps compromise patient care. I’ve found that these types of issues often stem from complex billing systems and incentives that prioritize financial gains over accurate medical reporting.
UnitedHealth Under Examination for Inflated risk Adjustments
Recent reports suggest UnitedHealth may have directed its providers to diagnose patients with more severe conditions than warranted, even without complete evaluations. Such as,the company allegedly encouraged diagnosing opioid dependence even in cases that didn’t meet the criteria for moderate or severe opioid use disorder. Similarly, guidance reportedly instructed providers to diagnose dementia without a comprehensive assessment, atrial fibrillation based on medication lists rather than actual diagnosis, and chronic obstructive pulmonary disease without required lung function tests.
These practices are at the heart of a civil and criminal investigation launched by the Department of Justice (DOJ).The DOJ’s investigation, disclosed in July, has intensified focus on UnitedHealth and the broader Medicare Advantage program. Did You Know? Medicare Advantage plans, while popular among seniors, have faced bipartisan criticism regarding costs and limitations on care.
The Centers for Medicare & Medicaid Services (CMS) Administrator, Dr. Mehmet Oz, has publicly stated his commitment to crack down on inflated risk adjustment in MA
. this builds upon previous efforts by the Biden governance, which already stopped payments for over 2,000 diagnosis codes deemed prone to upcoding. It’s a clear signal that regulators are taking these concerns seriously.
The Financial Impact of Risk Adjustment Changes
The Biden administration’s changes to risk adjustment have already impacted MA payers, including UnitedHealth. In April, the company’s stock experienced a significant drop after reporting disappointing first-quarter results.The stock has yet to fully recover, indicating investor concern. This demonstrates the financial consequences of stricter scrutiny and potential repayment obligations.
in response to these challenges and to restore confidence, UnitedHealth has been making changes. These include updating its executive team, reshaping its board of directors, and initiating a comprehensive review of its business practices.
